Bone Biologics Corporation (“Bone Biologics” or the “Company) (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, announces the filing of a patent application with ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
BURLINGTON, Mass., June 27, 2025--(BUSINESS WIRE)--Bone Biologics Corporation ("Bone Biologics" or the "Company) (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback